ZYNERBA PHARMACEUTICALS, INC. Research and Development Expense
ZYNERBA PHARMACEUTICALS, INC. reported Research and Development Expense of $7.17 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for the quarter ending 2023-06-30 was $7.17M, a 31.59% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for the quarter ending 2023-03-31 was $7.08M, a 37.53% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for the quarter ending 2022-12-31 was $5.47M, a 8.86% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for the quarter ending 2022-09-30 was $5.04M, a 20.53% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $21.10M, a 1.52% decline from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for fiscal 2021 was $21.42M, a 39.91% decline from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for fiscal 2020 was $35.65M, a 74.92% increase from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. research and development expense for fiscal 2019 was $20.38M, a 25.18% decline from fiscal 2018.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $7.17M 10-Q · filed 2023-08-14 | $14.24M 10-Q · filed 2023-08-14 | $19.71M derived: sum of 3 quarters · filed 2023-08-14 | $24.75M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $7.08M 10-Q · filed 2023-05-15 | $12.55M derived: sum of 2 quarters · filed 2023-05-15 | $17.58M derived: sum of 3 quarters · filed 2023-05-15 | $23.03M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $10.51M derived: sum of 2 quarters · filed 2023-03-28 | $15.95M derived: sum of 3 quarters · filed 2023-08-14 | $21.10M 10-K · filed 2023-03-28 |
| 2022-09-30 | $5.04M 10-Q · filed 2022-11-14 | $10.49M derived: sum of 2 quarters · filed 2023-08-14 | $15.63M 10-Q · filed 2022-11-14 | $20.65M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $5.45M 10-Q · filed 2023-08-14 | $10.59M 10-Q · filed 2023-08-14 | $15.62M derived: sum of 3 quarters · filed 2023-08-14 | $21.96M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $5.15M 10-Q · filed 2023-05-15 | $10.17M derived: sum of 2 quarters · filed 2023-05-15 | $16.51M derived: sum of 3 quarters · filed 2023-05-15 | $21.96M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $11.36M derived: sum of 2 quarters · filed 2023-03-28 | $16.82M derived: sum of 3 quarters · filed 2023-03-28 | $21.42M 10-K · filed 2023-03-28 |
| 2021-09-30 | $6.34M 10-Q · filed 2022-11-14 | $11.79M derived: sum of 2 quarters · filed 2022-11-14 | $16.40M 10-Q · filed 2022-11-14 | $22.02M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $5.45M 10-Q · filed 2022-08-10 | $10.06M 10-Q · filed 2022-08-10 | $15.68M derived: sum of 3 quarters · filed 2023-03-28 | $21.48M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $4.61M 10-Q · filed 2022-05-16 | $10.23M derived: sum of 2 quarters · filed 2023-03-28 | $16.03M derived: sum of 3 quarters · filed 2023-03-28 | $33.38M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $11.42M derived: sum of 2 quarters · filed 2023-03-28 | $28.77M derived: sum of 3 quarters · filed 2023-03-28 | $35.65M 10-K · filed 2023-03-28 |
| 2020-09-30 | $5.81M 10-Q · filed 2021-11-15 | $23.16M derived: sum of 2 quarters · filed 2021-11-15 | $30.04M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $17.35M 10-Q · filed 2021-08-09 | $24.23M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $6.88M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $20.38M 10-K · filed 2022-03-01 | |||
| 2019-06-30 | $8.22M 10-Q · filed 2020-08-10 | $14.53M 10-Q · filed 2020-08-10 | $19.41M derived: sum of 3 quarters · filed 2020-08-10 | $24.27M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $6.31M 10-Q · filed 2020-05-11 | $11.18M derived: sum of 2 quarters · filed 2020-05-11 | $16.04M derived: sum of 3 quarters · filed 2020-05-11 | $24.58M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $4.88M 10-K · filed 2019-03-11 | $9.74M derived: sum of 2 quarters · filed 2019-03-11 | $18.27M derived: sum of 3 quarters · filed 2019-08-06 | $27.25M 10-K · filed 2021-03-10 |
| 2018-09-30 | $4.86M 10-K · filed 2019-03-11 | $13.39M derived: sum of 2 quarters · filed 2019-08-06 | $22.37M 10-Q · filed 2018-11-08 | $28.20M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-06-30 | $8.53M 10-Q · filed 2019-08-06 | $17.51M 10-Q · filed 2019-08-06 | $23.34M derived: sum of 3 quarters · filed 2019-08-06 | $29.09M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $8.98M 10-Q · filed 2019-05-08 | $14.80M derived: sum of 2 quarters · filed 2019-05-08 | $20.56M derived: sum of 3 quarters · filed 2019-05-08 | $26.29M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $5.83M 10-K · filed 2019-03-11 | $11.58M derived: sum of 2 quarters · filed 2019-03-11 | $17.31M derived: sum of 3 quarters · filed 2019-03-11 | $22.81M 10-K · filed 2020-03-10 |
| 2017-09-30 | $5.75M 10-K · filed 2019-03-11 | $11.49M derived: sum of 2 quarters · filed 2019-03-11 | $16.98M 10-Q · filed 2018-11-08 | $21.88M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $5.73M 10-K · filed 2019-03-11 | $11.22M 10-Q · filed 2018-08-02 | $16.13M derived: sum of 3 quarters · filed 2019-03-11 | $20.63M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | $5.49M 10-K · filed 2019-03-11 | $10.40M derived: sum of 2 quarters · filed 2019-03-11 | $14.90M derived: sum of 3 quarters · filed 2019-03-11 | $19.71M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | $4.90M 10-K · filed 2018-03-12 | $9.41M derived: sum of 2 quarters · filed 2018-03-12 | $14.22M derived: sum of 3 quarters · filed 2018-03-12 | $16.78M 10-K · filed 2019-03-11 |
| 2016-09-30 | $4.50M 10-K · filed 2018-03-12 | $9.31M derived: sum of 2 quarters · filed 2018-03-12 | $11.88M 10-Q · filed 2017-11-14 | $15.19M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $4.81M 10-K · filed 2018-03-12 | $7.38M 10-Q · filed 2017-08-01 | $10.69M derived: sum of 3 quarters · filed 2018-03-12 | $12.96M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $2.57M 10-K · filed 2018-03-12 | $5.88M derived: sum of 2 quarters · filed 2018-03-12 | $8.15M derived: sum of 3 quarters · filed 2018-03-12 | $9.16M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $3.31M 10-K · filed 2017-03-27 | $5.58M derived: sum of 2 quarters · filed 2017-03-27 | $6.59M derived: sum of 3 quarters · filed 2017-03-27 | $7.45M 10-K · filed 2018-03-12 |
| 2015-09-30 | $2.27M 10-K · filed 2017-03-27 | $3.28M derived: sum of 2 quarters · filed 2017-03-27 | $4.14M 10-Q · filed 2016-11-14 | $4.95M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-06-30 | $1.01M 10-K · filed 2017-03-27 | $1.86M 10-Q · filed 2016-08-11 | $2.68M derived: sum of 3 quarters · filed 2017-03-27 | $3.61M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-03-31 | $853.70K 10-K · filed 2017-03-27 | $1.67M derived: sum of 2 quarters · filed 2017-03-27 | $2.60M derived: sum of 3 quarters · filed 2017-03-27 | $2.97M derived: sum of 4 quarters · filed 2017-03-27 |
| 2014-12-31 | $815.55K 10-K · filed 2016-03-14 | $1.75M derived: sum of 2 quarters · filed 2016-03-14 | $2.12M derived: sum of 3 quarters · filed 2016-03-14 | $2.40M 10-K · filed 2017-03-27 |
| 2014-09-30 | $932.84K 10-K · filed 2016-03-14 | $1.30M derived: sum of 2 quarters · filed 2016-03-14 | $1.59M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $367.30K 10-K · filed 2016-03-14 | $653.02K 10-Q · filed 2015-08-27 | ||
| 2014-03-31 | $285.73K 10-K · filed 2016-03-14 | |||
| 2013-12-31 | $1.13M 10-K · filed 2016-03-14 |